Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001415889-23-010719

VP, CFO acquired 167 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
DOTSON JERROLD DUANE VP, CFO 2023-06-30 Grant or award +167 $1.59 $265 3,671 D
Loading xslF345X04/form4-07052023_040701.xml…